Pipeline: Presbyopia treatment to finish Phase 3 late 2021

Video
Conference|Vision Expo East

Orasis Pharmaceuticals drop in development for treating presbyopia

Orasis Pharmaceuticals CEO Elad Kedar says the company is looking to achieve a balance of safety, efficacy, and comfort with its drop in development for treating presbyopia. He says Phase 3 studies should finish at the end of 2021.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.
The Vision Council CEO Ashley Mills overviews what is new and exciting at this year's show, running from February 19-22 in Orlando, Florida, and provides a free registration code for those still looking to register.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
Related Content
FDA accepts NDA for Tenpoint Therapeutics' brimochol PF for presbyopia ©Tada Images—stock.adobe.com

FDA accepts NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia

Emily Kaiser Maharjan, Assistant Managing Editor
June 3rd 2025
Article
Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

Maria Sampalis, OD;Kassi Filkins, Editor
April 27th 2023
Podcast
Older woman with glasses holding phone at distance Image credit: AdobeStock/KMPZZZ

Tenpoint Therapeutics submits NDA application to US FDA for brimochol PF for the treatment of presbyopia

Jordana Joy, Associate Editor
April 8th 2025
Article
Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

Emily Kaiser Maharjan, Assistant Managing Editor
April 26th 2023
Podcast
Man administering eye drops Image credit: AdobeStock/9nong

Orasis Pharmaceuticals’ prescription pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for presbyopia available in the US

Sheryl Stevenson, Eye Care Group Editorial Director;Jordana Joy, Associate Editor
April 7th 2025
Article
Woman taking off glasses to read phone Image credit: AdobeStock/kostikovanata

HOYA launches new advanced focus spectacle lenses for younger patients with presbyopia

Jordana Joy, Associate Editor
April 4th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.